Chronic lymphocytic leukemia

Chronic lymphocytic leukemia (CLL) is a type of cancer of the blood and bone marrow – the spongy tissue inside the bones where blood cells are made. The term “chronic” refers to the fact that it typically progresses more slowly than other types of leukemia.

Showing all 6 results

Filter our product list:
API
Antigen / Target
Therapeutic Areas
Therapeutic Indications
1
Classes of molecule​s
Isotypes
Expiry Date
CoA
Filters Sort results
Reset Apply

Product
Batch

Antigen
Molecular Class
Drug Brand
Product Concentration
CoA
Quantity per vial
Storage Temperature
Expiry Date
Price from
CD20
Monoclonal Antibody
Gazyvaro®
25 mg/mL
6 mg
-80°C
06/2019
279,90 
view product
Max: 10
Min: 1
Step: 1
CD20
Monoclonal Antibody
Gazyvaro®
25 mg/mL
6 mg
-80°C
08/2019
279,90 
view product
Max: 10
Min: 1
Step: 1
CD20
Biosimilar
,
Monoclonal Antibody
Ruxience®
10 mg/mL
2 mg
tba
tba
196,00 
view product
Max:
Min: 11
Step: 1
CD20
Biosimilar
,
Monoclonal Antibody
Truxima®
10 mg/mL
2 mg
tba
tba
234,00 
view product
Max:
Min: 10
Step: 1
CD20
Monoclonal Antibody
MabThera®
10 mg/mL
2 mg
-80°C
05/2018
126,90 
view product
Max: 10
Min: 3
Step: 1
CD20
Biosimilar
,
Monoclonal Antibody
Rixathon®
10 mg/mL
2 mg
-80 °C
03/2026
311,00 
view product
Max: 10
Min: 2
Step: 1

Not looking for Chronic lymphocytic leukemia?

Search our therapeutic molecules product database